Does RIOCIGUAT Cause Hepatic function abnormal? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Hepatic function abnormal have been filed in association with RIOCIGUAT (Adempas). This represents 0.1% of all adverse event reports for RIOCIGUAT.
23
Reports of Hepatic function abnormal with RIOCIGUAT
0.1%
of all RIOCIGUAT reports
9
Deaths
17
Hospitalizations
How Dangerous Is Hepatic function abnormal From RIOCIGUAT?
Of the 23 reports, 9 (39.1%) resulted in death, 17 (73.9%) required hospitalization, and 2 (8.7%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIOCIGUAT. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does RIOCIGUAT Cause?
Death (4,500)
Dyspnoea (2,881)
Headache (2,462)
Dizziness (2,208)
Hypotension (2,192)
Nausea (2,020)
Hospitalisation (1,864)
Diarrhoea (1,790)
Fatigue (1,638)
Vomiting (1,124)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which RIOCIGUAT Alternatives Have Lower Hepatic function abnormal Risk?
RIOCIGUAT vs RIPRETINIB
RIOCIGUAT vs RISANKIZUMAB
RIOCIGUAT vs RISANKIZUMAB-RZAA
RIOCIGUAT vs RISDIPLAM
RIOCIGUAT vs RISEDRONATE